<style type="text/css">body .wpex-vc-row-stretched, body .vc_row-o-full-height { visibility: visible; }</style> skip to Main Content


Advanced Search
  • Mar 12, 2012
    Galmed Phase II Aramchol Clinical Trial Successfully Demonstrates Safety and Positive Short-Term Effects for Treating Fatty Liver Disease

    Galmed Medical Research Ltd. announced today that Phase-II randomized, double blind trial results of its novel drug Aramchol for treating Fatty Liver Disease (NAFLD) has successfully confirmed the...

  • Dec 21, 2011

    Galmed Pharmaceuticals today announced the completion of a $5.5M financing round in the company. The round was led by private Venture Capital firm CH-Health, headed by Mr. Haim Hurvitz, a board...

Show 5102550100 per page
Back To Top